Novel “Predictor Patch” Method for Adding Predictors Using Estimates From Outside Datasets　― A Proof-of-Concept Study Adding Kidney Measures to Cardiovascular Mortality Prediction ―-Reference-Cited by-同舟云学术

Novel “Predictor Patch” Method for Adding Predictors Using Estimates From Outside Datasets　― A Proof-of-Concept Study Adding Kidney Measures to Cardiovascular Mortality Prediction ―

Published:2019-08-23 Issue:9 Volume:83 Page:1876-1882
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Matsushita Kunihiro¹,Sang Yingying¹,Chen Jingsha¹,Ballew Shoshana H.¹,Shlipak Michael²,Coresh Josef¹,Peralta Carmen A.²,Woodward Mark¹³⁴

Affiliation:

1. Johns Hopkins University

2. University of California San Francisco

3. The George Institute for Global Health, University of New South Wales

4. The George Institute for Global Health, University of Oxford

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/83/9/83_CJ-19-0320/_pdf

Reference21 articles.

1. 1. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: S1–S45.

2. 2. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71: e127–e248.

3. 3. Blood Pressure Lowering Treatment Trialists Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data. Lancet 2014; 384: 591–598.

4. 4. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.

5. 5. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: S49–S73.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of the American Heart Association’s PREVENT Equations;Circulation;2024-02-06

2. Combined Prognostic Value of Preprocedural Protein–Energy Wasting and Inflammation Status for Amputation and/or Mortality after Lower-Extremity Revascularization in Hemodialysis Patients with Peripheral Arterial Disease;Journal of Clinical Medicine;2023-12-25

3. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP;European Journal of Preventive Cardiology;2022-08-16

4. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study;Journal of the American Society of Nephrology;2022-03

5. Chronic kidney disease measures for cardiovascular risk prediction;Atherosclerosis;2021-10